OPTN | OptiNose, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	6.17 - 7.32
52 Week Range	4.82 - 31.50
Beta	-0.09
Implied Volatility	271.82%
IV Rank	64.36%
Day's Volume	133,611
Average Volume	63,599
Shares Outstanding	10,055,300
Market Cap	69,582,676
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2017-10-13

Valuation
Profitability
Growth
Health
P/E Ratio	-1.59
Forward P/E Ratio	-4.53
EPS	-4.35
1YR Price Target	8.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	132
Country	USA
Website	OPTN

OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.

OPTN's peers: COLL, PAHC, ANIP, PROC, SSIC, LFCR, KMDA, SHPH, CPIX, IRWD, AMPH, EGRX, ALKS, EOLS, PBH, RGC, NBIX, ITCI, DCPH, DVAX

*Chart delayed

Analyzing fundamentals for OPTN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is exceptionally good and Health is frighteningly weak. For more detailed analysis please see OPTN Fundamentals page.

Watching at OPTN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on OPTN Technicals page.